arginine has been researched along with Thrombophlebitis in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 20 (80.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, Y; Doi, M; Murawaki, A; Nakashima, K; Nakayasu, H; Omura, H; Suzuki-Kinoshita, K | 1 |
| Mattson, JC; Smythe, MA; Stephens, JL; Warkentin, TE; Zakalik, D | 1 |
| Lefebvre, PJ; Luyckx, AS | 1 |
| Abiko, Y; Kumada, T | 1 |
| Aiach, M; Alhenc-Gelas, M; Aubry, ML; Benaily, N; Emmerich, J; Fiessinger, JN; Gandrille, S | 1 |
| Abe, H; Okabe, H; Okajima, K; Takatsuki, K; Wagatsuma, M | 1 |
| Berry, CN; Girard, D; Lecoffre, C; Lochot, S | 1 |
| Dahlbäck, B; Zöller, B | 1 |
| Dahlbäck, B; He, X; Svensson, PJ; Zöller, B | 1 |
| Bignell, P; Cooper, DN; Girolami, A; Girolami, B; Kakkar, VV; Marchiori, A; Millar, DS; Simioni, P | 1 |
| Beamer, N; Coull, BM; Liu, XY; Press, RD | 1 |
| Borchiellini, A; Montaruli, B; Muleo, G; Pannocchia, A; Schinco, P; Tamponi, G; van Mourik, JA; Voorberg, J | 1 |
| Alving, BM; Carrington, LR; Gillespie, DL; Griffin, JH | 1 |
| Börjesson, I; Elg, M; Gustafsson, D; Lenfors, S; Teger-Nilsson, AC | 1 |
| Lew Andowski, KL; Markiewicz, WT; Rozek, M; Turowiecka, Z; Zawilska, K | 1 |
| Koide, T; Tokunaga, F; Tsukamoto, T | 1 |
| Brenner, B; Conard, J; Eldor, A; Griffin, JH; Pabinger, I; Samama, M; Seligsohn, U; Xu, X; Zivelin, A | 1 |
| Grohmann, J; Koch, HG; Nowak-Göttl, U; Schneppenheim, R; Vielhaber, H | 1 |
| Binder, M; Dübbers, A; Kehrel, B; Koch, HG; Nowak-Göttl, U; Veltmann, H; Vielhaber, H | 1 |
| Berry, CN; Charles, MC; Ferrari, P; Girard, D; Girardot, C; Lechaire, I; Lunven, C; O'Brien, DP | 1 |
| Hirayama, F; Hisamichi, N; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y | 1 |
| Griffin, JH; Petäjä, JM | 1 |
| Bathelier, C; Champenois, T; Lucotte, G | 1 |
| Brajerski, W | 1 |
| Cooper, DN; Grundy, CB; Kakkar, VV; Schulman, S; Tengborn, L | 1 |
4 review(s) available for arginine and Thrombophlebitis
| Article | Year |
|---|---|
[The glucagonomas (author's transl)].
Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc | 1981 |
Protein C infusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gln and Arg-1 to His.
Topics: Arginine; Codon; DNA Mutational Analysis; Drug Therapy, Combination; Female; Genes; Glycine; Heparin, Low-Molecular-Weight; Heterozygote; Histidine; Humans; Middle Aged; Pedigree; Protein C; Protein C Deficiency; Thrombophlebitis | 1995 |
[Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C].
Topics: Adult; Arginine; Base Sequence; Disease Susceptibility; Factor V; Guanosine; Humans; Male; Molecular Sequence Data; Pedigree; Point Mutation; Protein C; Thrombophlebitis | 1996 |
[Plasma clotting system in neoplastic diseases].
Topics: Animals; Arginine; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Humans; Neoplasms; Platelet Aggregation; Thrombophlebitis; Thrombosis | 1976 |
21 other study(ies) available for arginine and Thrombophlebitis
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia in essential thrombocytosis.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Bone Marrow Examination; Cerebral Infarction; Constriction, Pathologic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Femoral Artery; Heparin; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Predictive Value of Tests; Sulfonamides; Thrombocythemia, Essential; Thrombocytopenia; Thrombophlebitis; Treatment Outcome | 2012 |
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Arginine; Autoimmune Diseases; Catheterization, Central Venous; Contraindications; Drug Administration Schedule; Drug Therapy, Combination; Female; Gangrene; Heparin; Hirudin Therapy; Hirudins; Humans; International Normalized Ratio; Leg; Male; Middle Aged; Necrosis; Pipecolic Acids; Protein C Deficiency; Recombinant Proteins; Sulfonamides; Surgical Wound Infection; Thrombin; Thrombocytopenia; Thrombophlebitis; Warfarin | 2002 |
Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals.
Topics: Acute Disease; Animals; Antibodies, Anti-Idiotypic; Antigens; Antithrombin III; Arginine; Blood Coagulation Tests; Fibrinolytic Agents; Heparin; Male; Mice; Mice, Inbred Strains; Pipecolic Acids; Pulmonary Embolism; Rabbits; Rats; Rats, Inbred Strains; Sulfonamides; Thrombin; Thrombophlebitis | 1981 |
Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
Topics: Adult; Antithrombin III; Arginine; Base Sequence; Chromatography, Affinity; Factor X; Female; Heparin; Histidine; Humans; Immunoelectrophoresis, Two-Dimensional; Molecular Sequence Data; Mutation; Pedigree; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Thrombin; Thrombophlebitis | 1995 |
Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
Topics: Animals; Arginine; Arteriovenous Shunt, Surgical; Bleeding Time; Carotid Arteries; Electric Stimulation; Fibrinolytic Agents; Heparin; Male; Pipecolic Acids; Rats; Sulfonamides; Tail; Thrombophlebitis; Thrombosis | 1994 |
Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
Topics: Alleles; Arginine; Base Sequence; DNA; DNA Primers; Factor V; Female; Genetic Linkage; Humans; Male; Molecular Sequence Data; Partial Thromboplastin Time; Pedigree; Point Mutation; Polymerase Chain Reaction; Protein C; Protein S Deficiency; Radioimmunoassay; Thrombophlebitis | 1994 |
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
Topics: Arginine; Base Sequence; Drug Resistance; Enzyme Activation; Factor V; Female; Genetic Predisposition to Disease; Glutamine; Heterozygote; Homozygote; Humans; Male; Molecular Sequence Data; Point Mutation; Protein C; Risk Factors; Survival Analysis; Sweden; Thrombophlebitis | 1994 |
A novel dysfunctional protein C (protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg-1 results in a strongly reduced affinity for binding of Ca++.
Topics: Adult; Aged; Antigens; Arginine; Base Sequence; Calcium; Child; Cysteine; Humans; Immunoblotting; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Polymerase Chain Reaction; Protein C; Pulmonary Embolism; Thrombophlebitis | 1993 |
Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C.
Topics: Adult; Aged; Arginine; Brain Ischemia; Case-Control Studies; Cerebrovascular Disorders; Factor V; Female; Fibrinolytic Agents; Heterozygote; Humans; Infant, Newborn; Male; Middle Aged; Phenotype; Point Mutation; Polymerase Chain Reaction; Prevalence; Protein C; Risk Factors; Thrombophlebitis | 1996 |
Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.
Topics: Adult; Arginine; Base Sequence; Factor V; Female; Glutamine; Heterozygote; Homozygote; Humans; Italy; Male; Molecular Sequence Data; Mutation; Myocardial Infarction; Pedigree; Thrombophlebitis; Thrombosis | 1996 |
Resistance to activated protein C: a common inherited cause of venous thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Arginine; Contraceptives, Oral; DNA; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Mutation; Obesity; Pregnancy; Protein C; Protein C Deficiency; Protein S Deficiency; Recurrence; Risk Factors; Thromboembolism; Thrombophlebitis | 1996 |
Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.
Topics: Animals; Antithrombins; Arginine; Aspirin; Bleeding Time; Disease Models, Animal; Fibrinolytic Agents; Glycine; Heparin; Male; Molecular Weight; Pipecolic Acids; Piperidines; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombolytic Therapy; Thrombophlebitis; Thrombosis | 1996 |
Cellular basis for protein C deficiency caused by a single amino acid substitution at Arg15 in the gamma-carboxyglutamic acid domain.
Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Cell Line; Cricetinae; DNA Primers; Endoplasmic Reticulum; Humans; Molecular Structure; Mutagenesis, Site-Directed; Point Mutation; Protein C; Protein C Deficiency; Recombinant Proteins; Thrombophlebitis; Transfection | 1996 |
A single genetic origin for a common Caucasian risk factor for venous thrombosis.
Topics: Arginine; Factor V; Haplotypes; Humans; Point Mutation; Polymorphism, Genetic; Risk Factors; Thrombophlebitis; White People | 1997 |
Arginine506 to glutamin mutation in the factor V gene in infancy and childhood: evidence of fibrinolytic impairment.
Topics: Adolescent; Arginine; Child; Child, Preschool; DNA Mutational Analysis; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Genetic Carrier Screening; Genetic Predisposition to Disease; Glutamine; Homozygote; Humans; Infant; Infant, Newborn; Male; Oligopeptides; Protein C; Thrombin; Thrombophlebitis | 1997 |
Arg506 to Gln mutation in the factor V gene causes poor fibrinolytic response in children after venous occlusion.
Topics: Arginine; Child; Factor V; Fibrinolysis; Glutamine; Humans; Plasminogen Activator Inhibitor 1; Point Mutation; Protein C; Thrombophlebitis; Tissue Plasminogen Activator | 1997 |
Ecarin Clotting Time: a predictive coagulation assay for the antithrombotic activity of argatroban in the rat.
Topics: Animals; Antithrombins; Arginine; Arteriovenous Shunt, Surgical; Blood Coagulation Tests; Disease Models, Animal; Male; Pipecolic Acids; Rats; Rats, Inbred Strains; Reference Values; Sulfonamides; Thrombophlebitis; Thromboplastin; Thrombosis; Treatment Outcome | 1998 |
Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
Topics: Animals; Anticoagulants; Arginine; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Proteins; Dalteparin; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; In Vitro Techniques; Male; Naphthalenes; Partial Thromboplastin Time; Pipecolic Acids; Piperidines; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombophlebitis; Thrombosis | 1998 |
Activated protein C resistance: What have we learned now that the dust has settled?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation Disorders; Cerebrovascular Disorders; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophlebitis; Thrombosis | 1997 |
ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
Topics: Alleles; Amino Acid Substitution; Arginine; Factor V; France; Gene Frequency; Glutamine; Humans; Point Mutation; Thrombophlebitis | 1998 |
Two different missense mutations at Arg 178 of the protein C (PROC) gene causing recurrent venous thrombosis.
Topics: Arginine; Base Sequence; Exons; Female; Heterozygote; Humans; Male; Molecular Sequence Data; Mutation; Pedigree; Protein C; Protein C Deficiency; Recurrence; Thrombophlebitis | 1992 |